P2Y12 inhibitors during and after acute coronary syndrome, where do we stand in 2020?
Antithrombotic therapy for patients with STEMI undergoing primary PCI | Nature Reviews Cardiology
Current guideline recommendations on P2Y 12 receptor directed treatment... | Download Table
Tailoring P2Y12 Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | Journal of the American Heart Association
PDF) Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: An observational comparative study
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.,JAMA - X-MOL
Effectiveness and Safety of Platelet ADP–P2Y12 Receptor Inhibitors Influenced by Smoking Status: A Systematic Review and Meta‐Analysis | Journal of the American Heart Association
Poll Results: Preload With P2Y12 Inhibitor - American College of Cardiology
JCM | Free Full-Text | P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | HTML
Myo.infarction
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet
Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry | Revista Española de Cardiología (English Edition)
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention - ScienceDirect
![Fig. 8.1, [Switching of P2Y12 inhibitor product in acute setting []]. - Primary Angioplasty - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK543598/bin/454380_1_En_8_Fig1_HTML.jpg "Fig. 8.1, [Switching of P2Y12 inhibitor product in acute setting []]. - Primary Angioplasty - NCBI Bookshelf")
Fig. 8.1, [Switching of P2Y12 inhibitor product in acute setting []]. - Primary Angioplasty - NCBI Bookshelf
stemi
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI - International Journal of ...
![PDF] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a00275204b744cd63f1a792ad9748b856dc6bc2b/5-Figure1-1.png "PDF] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. | Semantic Scholar")
PDF] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. | Semantic Scholar
Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PEN
Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI | SpringerLink
Contemporary Antiplatelet Strategies in the Treatment of STEMI using Primary Percutaneous Coronary Intervention | ICR Journal
Initial and long-term management of acute coronary syndromes in the UK.... | Download Scientific Diagram
